Capoten and Staphylococcal bacteraemia - a phase IV clinical study of FDA data

Summary:

Staphylococcal bacteraemia is reported only by a few people who take Capoten.

The phase IV clinical study analyzes which people take Capoten and have Staphylococcal bacteraemia. It is created by eHealthMe based on reports of 2,908 people who have side effects while taking Capoten from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 01, 2022

2,908 people reported to have side effects when taking Capoten.
Among them, 2 people (0.07%) have Staphylococcal bacteraemia.


What is Capoten?

Capoten has active ingredients of captopril. It is often used in high blood pressure. eHealthMe is studying from 2,931 Capoten users for its effectiveness, alternative drugs and more.

What is Staphylococcal bacteraemia?

Staphylococcal bacteraemia (a bacterial infection of blood) is found to be associated with 1,031 drugs and 585 conditions by eHealthMe.

Number of Capoten and Staphylococcal bacteraemia reports submitted per year:

Could Capoten cause Staphylococcal bacteraemia?

Gender of people who have Staphylococcal bacteraemia when taking Capoten *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Staphylococcal bacteraemia when taking Capoten *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Capoten *:

  1. Zaroxolyn: 2 people, 100.00%
  2. Lasix: 2 people, 100.00%
  3. Lantus: 2 people, 100.00%
  4. Heparin: 2 people, 100.00%
  5. Levaquin: 1 person, 50.00%
  6. Keflex: 1 person, 50.00%
  7. Imdur: 1 person, 50.00%
  8. Hydroxyzine: 1 person, 50.00%
  9. Humalog Kwikpen: 1 person, 50.00%
  10. Furosemide: 1 person, 50.00%

Common side effects people have besides Staphylococcal bacteraemia *:

  1. Wound Infection Staphylococcal: 1 person, 50.00%
  2. Fatigue (feeling of tiredness): 1 person, 50.00%
  3. Diabetes Mellitus Inadequate Control: 1 person, 50.00%
  4. Diarrhea: 1 person, 50.00%
  5. Dilatation Ventricular: 1 person, 50.00%
  6. Disease Recurrence: 1 person, 50.00%
  7. Dizziness: 1 person, 50.00%
  8. Electrocardiogram Abnormal: 1 person, 50.00%
  9. Enterobacter Bacteraemia (enterobacter cloacae are nosocomial pathogens that can cause a range of infections such as bacteraemia, lower respiratory tract infection, skin): 1 person, 50.00%
  10. Fall: 1 person, 50.00%

Common conditions people have *:

  1. Limb Injury: 1 person, 50.00%
  2. Dry Skin: 1 person, 50.00%
  3. Diabetes: 1 person, 50.00%
  4. Chest Pain: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Capoten and have Staphylococcal bacteraemia?

Check whether Staphylococcal bacteraemia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Staphylococcal bacteraemia and when was it recovered:

Expand to all the drugs that have ingredients of captopril:

Alternative drugs to, pros and cons of Capoten:

Common Capoten side effects:

Browse all side effects of Capoten:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Staphylococcal bacteraemia treatments and more:

COVID vaccines that are related to Staphylococcal bacteraemia:

Common drugs associated with Staphylococcal bacteraemia:

All the drugs that are associated with Staphylococcal bacteraemia:

Common conditions associated with Staphylococcal bacteraemia:

All the conditions that are associated with Staphylococcal bacteraemia:

How the study uses the data?

The study uses data from the FDA. It is based on captopril (the active ingredients of Capoten) and Capoten (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: